Zobrazeno 1 - 10
of 20
pro vyhledávání: '"LaVerne A. Mooney"'
Publikováno v:
Current Medical Research and Opinion. 35:1221-1230
Objective: To examine how medical journal editors perceive changes in transparency and credibility of industry-sponsored clinical trial publications over a 5 year period (2010 to 2015). Methods: From July to September 2015, a survey link was emailed
Autor:
LaVerne A. Mooney, Dan Bridges, Karen L. Woolley, Angela Cairns, Wendy P Battisti, James A Gurr, Elizabeth Wager, Carol Sanes-Miller, Teresa Peña, B. Jane Moore, Keith Veitch, Yvonne E Yarker, Leslie Citrome, Lise Baltzer, Christopher I. Carswell
Publikováno v:
Annals of Internal Medicine. 163:461-464
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmace
Autor:
LaVerne A. Mooney, Lorna Fay
Publikováno v:
BMJ Open
Objective To estimate the proportion of Pfizer-sponsored clinical trials that completed in 2010 and are published as manuscripts in the peer-reviewed literature, and to assess the manuscript development history. Design Retrospective, cross-sectional
Autor:
Robert E. Enck, Philip D. Walson, Al Weigel, Juli Clark, Trish Groves, Michelle Evangelista, John Gonzalez, Frank S. David, Leslie Citrome, Charles Miller, Jay Magrann, Bernadette Mansi, LaVerne A. Mooney, Ann Murphy, John Shelton, Leighton Chipperfield
Publikováno v:
Current Medical Research and Opinion. 26:1967-1982
Biomedical journals and the pharmaceutical industry share the goals of enhancing transparency and expanding access to peer-reviewed research; both industries have recently instituted new policies and guidelines to effect this change. However, while i
Autor:
Juli Clark, John Gonzalez, LaVerne A. Mooney, Charles Miller, Elizabeth Wager, Bernadette Mansi, A. Weigel, M. Schreiweis, Duncan Richards, K. Mosdell
Publikováno v:
International Journal of Clinical Practice. 64:1028-1033
Industry-sponsored clinical research has become more open and transparent in recent years (1), spurred by changes in policy, regulation and technology, and fostered by a general trend towards increased information access and sharing, which is also ap
Autor:
M. Kim, Deliang Tang, Andrew Rundle, Manuela Orjuela, A. Madsen, LaVerne A. Mooney, F.P. Perera
Publikováno v:
Biomarkers. 12:123-132
Prior work suggests that body size and fat content may influence carcinogen-DNA adduct levels measured in white blood cells. Here we consider energy balance more broadly by assessing the impact of body mass index (BMI), physical activity and calorie
Autor:
LaVerne A. Mooney, Ann M. Madsen, Deliang Tang, Manuela A. Orjuela, Wei-Yann Tsai, Elizabeth R. Garduno, Frederica P. Perera
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 14:237-242
Background: Elevated benzo(a)pyrene [B(a)P]-DNA adducts have been associated with 3-fold increased risk of lung cancer in current smokers. We assessed the chemopreventive effects of antioxidant supplementation using B(a)P-DNA adducts in leukocytes as
Autor:
Douglas A. Bell, F.P. Perera, Lirio S. Covey, LaVerne A. Mooney, Regina M. Santella, T. L. Young, A M Van Bennekum, George W. Lucier, William S. Blaner, Thomas B. Cooper, A H Glassman, Ruth Ottman, Myunghee Cho Paik
Publikováno v:
Carcinogenesis. 18:503-509
Prior epidemiological evidence suggests that genes controlling the metabolism of carcinogens and antioxidant/nutritional status are associated with lung cancer risk, possibly through their ability to modulate DNA damage by carcinogens. We performed a
Autor:
LaVerne A. Mooney, Frederica P. Perera
Publikováno v:
Journal of Cellular Biochemistry. 63:63-68
Molecular epidemiology has made great progress in detecting and documenting carcinogenic exposures and host susceptibility factors, in an effort to explain interindividual variation in disease. Interindividual differences in cancer risk have been hyp
Autor:
K. Savela, R. R. Perera, Regina M. Santella, Wei-Yann Tsai, J. P. O'neill, K. Hemminki, LaVerne A. Mooney, R. J. Albertini, Ruth Ottman, Chris Dickey
Publikováno v:
Carcinogenesis. 15:2905-2910
Carcinogen-DNA adducts and somatic gene mutation at the hypoxanthine guanine phosphoribosyl transferase (HPRT) locus were evaluated in peripheral leukocytes of workers in an iron foundry with exposure to benzo[a]pyrene (B[a]P) and other polycyclic ar